US Patent 10968180 Piperidine derivatives as HDAC1/2 inhibitors
Patent 10968180 was granted and assigned to Regenacy Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10968180 Piperidine derivatives as HDAC1/2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
